文献速递区域麻醉与超声术前评估与围术期医学

脂肪乳预处理降低膝关节以下骨折手术股神经和坐骨神经阻滞时左布比卡因的最大总浓度和游离浓度

Lipid Emulsion Pretreatment Decreased the Maximum Total and Free Plasma Concentration of Levobupivacaine for Femoral and Sciatic Nerve Block in Below-Knee Fracture Surgery.
PubMed 文献 · Reg Anesth Pain Med · 2018-01-01

该随机对照研究纳入12例膝关节以下骨折手术患者,比较脂肪乳预处理(1.5 mL/kg)与生理盐水预处理后行股神经和坐骨神经阻滞(0.375%左布比卡因2.5 mg/kg)的药效学和药代动力学。结果显示脂肪乳组左布比卡因最大总浓度和游离浓度均显著低于对照组,表观分布容积和清除率更高,甘油三酯水平显著升高。结论提示脂肪乳预处理可降低左布比卡因最大血浆浓度,为脂肪乳影响局麻药毒性提供人体药代动力学解释。

要点

  • 脂肪乳预处理降低左布比卡因最大总浓度和游离浓度。
  • 脂肪乳组表观分布容积和清除率高于对照组。
  • 脂肪乳预处理后甘油三酯水平显著升高。

核心结论

  • 脂肪乳预处理增加左布比卡因表观分布容积和清除率,降低最大总浓度和游离浓度。
  • 快速脂肪乳输注引起高甘油三酯血症,本研究未观察到其他明显风险。

研究设计与样本

  • 随机对照研究,12例膝关节以下骨折手术患者随机分为脂肪乳组和对照组,每组6例。
  • 脂肪乳组预处理输注1.5 mL/kg脂肪乳,对照组输注生理盐水,随后行股神经和坐骨神经阻滞,使用0.375%左布比卡因2.5 mg/kg。

主要发现

  • 脂肪乳组最大总血浆左布比卡因浓度为865 ± 98 μg/L,对照组为1145 ± 177 μg/L(P < 0.01)。
  • 脂肪乳组最大游离血浆左布比卡因浓度为56.8 ± 7.5 μg/L,对照组为78.2 ± 13.7 μg/L(P < 0.01)。
  • 脂肪乳组表观分布容积为211 ± 35 L,对照组为170 ± 21 L(P < 0.05)。
  • 脂肪乳组清除率为35.1 ± 8.0 L/h,对照组为25.8 ± 2.6 L/h(P < 0.05)。
  • 脂肪乳组输注结束时甘油三酯水平为7.59 ± 1.32 mmol/L,基线为1.34 ± 0.39 mmol/L(P < 0.01)。

临床怎么用

  • 脂肪乳预处理可能通过增加分布容积和清除率降低左布比卡因最大血浆浓度,但需注意甘油三酯升高。
  • 该策略的临床获益与风险需进一步研究,目前不推荐常规用于预防局麻药毒性。

局限性

  • 样本量小(共12例),每组仅6例。
  • 研究仅评估单次剂量左布比卡因和特定神经阻滞,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Although intravenous lipid emulsion has been proved a powerful antidote for local anesthetic toxicity, there are few pharmacokinetic data on using lipid infusion as a pretreatment for other clinical applications. We assessed the influence of lipid pretreatment on the pharmacodynamics and pharmacokinetics of levobupivacaine. METHODS: Altogether, 12 patients undergoing below-knee surgery for a fracture were randomly assigned to 2 groups (6 patients per group): pretreatment with 1.5 mL/kg lipid infusion (lipid group) or saline infusion (control subjects) followed by complete femoral and sciatic nerve block with 0.375% levobupivacaine (2.5 mg/kg). Total and free (non-protein bound) plasma levobupivacaine concentrations and triglycerides in the lipid group were determined. RESULTS: Results were given as means ± SD. Total and free maximum plasma levobupivacaine concentrations were lower in the lipid group than in control subjects (865 ± 98 vs 1145 ± 177 μg/L and 56.8 ± 7.5 vs 78.2 ± 13.7 μg/L, respectively; P < 0.01). Apparent volume of distribution and clearance were higher in the lipid group than in control subjects (211 ± 35 vs 170 ± 21 L and 35.1 ± 8.0 vs 25.8 ± 2.6 L/h, respectively; P < 0.05). Triglyceride level was significantly higher at the end of lipid infusion than baseline values (7.59 ± 1.32 vs 1.34 ± 0.39 mmol/L; P < 0.01). CONCLUSIONS: Lipid pretreatment increased the apparent volume of distribution and clearance and decreased the maximum total and free levobupivacaine concentrations, thus offering a reasonable explanation for the effects of lipids on local anesthesia-related toxicity in humans. Rapid lipid infusion induced hypertriglyceridemia without other apparent risks in this study. CLINICAL TRIAL REGISTRATION: This study was registered at the Chinese Clinical Trial Registry, identifier ChiCTR-TRC-14005203.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Chen Y, Zhang J, Chen Z, et al. Lipid Emulsion Pretreatment Decreased the Maximum Total and Free Plasma Concentration of Levobupivacaine for Femoral and Sciatic Nerve Block in Below-Knee Fracture Surgery. Reg Anesth Pain Med. 2018. PMID: 29923955. doi:10.1097/AAP.0000000000000834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。